Autologous Cell Therapy Market Projected to Reach USD 34.7 Billion by 2027 with a CAGR of 18.1%
Aug 22, 2024
Therapy Equities
Study Reveals Link Between Suggestibility and Antidepressant Response in Psychedelic Therapy
Jan 28, 2024
MAPS Public Benefit Corporation Raises Over $100M for MDMA Therapy Advancements
Jan 13, 2024
Introduction of New CPT III Codes for Psychedelic-Assisted Therapies by MAPS PBC
Jan 3, 2024
Immix Biopharma Reports Unprecedented 100% ORR for CAR-T NXC-201 in AL Amyloidosis at ASH 2023
Dec 12, 2023
U.K. Authorizes Groundbreaking Gene Therapy for Sickle Cell Disease
Nov 17, 2023